Lawrence W. Hamilton
CIK: 0001326586
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)2 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
TMCI
TREACE MEDICAL CONCEPTS, INC.
Director
Discretionary Trading P&L
Holdings
About HAMILTON LAWRENCE W
HAMILTON LAWRENCE W (SEC CIK 0001326586) files insider reports with the SEC as Director of TREACE MEDICAL CONCEPTS, INC. (TMCI).
Signal8 holds 2 ownership filings by HAMILTON LAWRENCE W, all Form 4s, filed between May 21, 2025 and May 19, 2026. Those filings report 2 transactions, from May 20, 2025 to May 19, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on HAMILTON LAWRENCE W's filings is in PONTE VEDRA, FL.
Recent filings by HAMILTON LAWRENCE W
Other insiders filing for TREACE MEDICAL CONCEPTS, INC. (TMCI)
- Scanlan Sean F., Chief Innovation Officer
- Elder Scot Michael, Chief Legl & Comp Off, CorpSec
- Treace John T., Chief Executive Officer
- Hair Mark, Chief Financial Officer
- BAKEWELL JOHN K, Director
- Kiernan Jane E, Director